• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

S期分数和绝经状态是乳腺癌淋巴结阴性患者无病生存最重要的预后因素。一项前瞻性研究。

S-phase fraction and menopausal status as the most important prognostic factors of disease-free survival for node negative patients with breast cancer. A prospective study.

作者信息

Lackowska Bozena, Niezabitowski Aleksander, Ryś Janusz, Skołyszewski Jan, Stelmach Andrzej, Gruchała Andrzej, Jaszcz-Gruchała Agnieszka

机构信息

Department of Pathology, Oncology Center, Kraków.

出版信息

Pol J Pathol. 2003;54(2):101-10.

PMID:14575418
Abstract

The aim of our study was to determine a prognostic value of DNA flow cytometry measurements performed on fresh breast cancer tissues, separately for patients' groups defined by nodal status, with special attention to histological type of tumor. Between 1993 and 1996 samples from 677 patients were analyzed and 457 cases were included in the survival analysis. Two-hundred and nine patients from them were node negative (N0). The median time of follow-up was 74 months. In multivariate analysis of disease-free survival (DFS), S-phase fraction (SPF) and menopausal status were found to be independent prognostic parameters for N0 group. A combination of this factors allowed us to distinguish three groups different in respect of the risk of recurrence. Our results showed that: 1. SPF and menopausal status could be prognostically valuable factors for DFS in N0 breast cancer patients; 2. prognostic value of SPF and ploidy should be evaluated separately for each histological type of breast cancer.

摘要

我们研究的目的是确定对新鲜乳腺癌组织进行DNA流式细胞术测量的预后价值,分别针对按淋巴结状态定义的患者组,特别关注肿瘤的组织学类型。1993年至1996年间,对677例患者的样本进行了分析,457例病例纳入生存分析。其中209例患者为淋巴结阴性(N0)。中位随访时间为74个月。在无病生存期(DFS)的多变量分析中,发现S期分数(SPF)和绝经状态是N0组的独立预后参数。这些因素的组合使我们能够区分出复发风险不同的三组。我们的结果表明:1. SPF和绝经状态可能是N0期乳腺癌患者DFS的预后有价值因素;2. 应针对每种组织学类型的乳腺癌分别评估SPF和倍性的预后价值。

相似文献

1
S-phase fraction and menopausal status as the most important prognostic factors of disease-free survival for node negative patients with breast cancer. A prospective study.S期分数和绝经状态是乳腺癌淋巴结阴性患者无病生存最重要的预后因素。一项前瞻性研究。
Pol J Pathol. 2003;54(2):101-10.
2
Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.联合流式细胞术测定S期细胞比例和DNA倍体是淋巴结阴性浸润性乳腺癌的独立预后因素:对271例I期和II期乳腺癌患者的系列分析
Breast Cancer Res Treat. 2005 May;91(1):61-71. doi: 10.1007/s10549-004-7047-1.
3
[Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].[联合流式细胞术测定S期分数和DNA倍体是淋巴结阴性浸润性乳腺癌的独立预后因素:对271例I期和II期乳腺癌患者的系列研究回顾]
Cancer Radiother. 2005 Dec;9(8):575-86. doi: 10.1016/j.canrad.2005.09.016. Epub 2005 Oct 20.
4
S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients.细针穿刺抽吸物中测定的S期分数是乳腺癌的独立预后因素——一项对770例患者的多变量研究。
Cytopathology. 2008 Oct;19(5):294-302. doi: 10.1111/j.1365-2303.2007.00528.x. Epub 2007 Dec 7.
5
S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric study.633例T1T2期乳腺癌的S期细胞分数和DNA倍体:一项标准化流式细胞术研究
Clin Cancer Res. 2001 Apr;7(4):909-17.
6
Prognostic markers in node-negative breast cancer: a prospective study.腋窝淋巴结阴性乳腺癌的预后标志物:一项前瞻性研究。
Cytometry B Clin Cytom. 2004 May;59(1):24-31. doi: 10.1002/cyto.b.20003.
7
Prognostic value of DNA ploidy using flow cytometry in 1301 breast cancer patients: results of the prospective Multicenter Morphometric Mammary Carcinoma Project.流式细胞术检测DNA倍体在1301例乳腺癌患者中的预后价值:前瞻性多中心乳腺形态计量学癌项目的结果
Mod Pathol. 1997 Aug;10(8):762-8.
8
Flow cytometry in primary breast carcinomas: prognostic impact of multiploidy and hypoploidy.原发性乳腺癌中的流式细胞术:多倍体和亚二倍体的预后影响。
Cytometry B Clin Cytom. 2003 Sep;55(1):37-45. doi: 10.1002/cyto.b.10040.
9
[Flow cytometry detected S-phase fraction and ploidy as prognostic parameters in primary, node-negative breast cancer].[流式细胞术检测S期分数和倍性作为原发性、淋巴结阴性乳腺癌的预后参数]
Geburtshilfe Frauenheilkd. 1994 May;54(5):291-4. doi: 10.1055/s-2007-1022842.
10
DNA flow cytometry but not telomerase activity as predictor of disease-free survival in pT1-2/N0/G2 breast cancer.DNA流式细胞术而非端粒酶活性可作为pT1-2/N0/G2期乳腺癌无病生存期的预测指标。
Pathobiology. 2006;73(2):63-70. doi: 10.1159/000094490.